Review ArticleReview
Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
Mari Mino-Kenudson
Cancer Biology & Medicine June 2016, 13 (2) 157-170; DOI: https://doi.org/10.20892/j.issn.2095-3941.2016.0009
Mari Mino-Kenudson
1Department of Pathology, Massachusetts General Hospital & Harvard Medical School, Boston, MA 02114-2696, USA
References
- 1.↵
- Patel JD,
- Krilov L,
- Adams S,
- Aghajanian C,
- Basch E,
- Brose MS, et al.
- 2.↵
- Ettinger DS,
- Wood DE,
- Akerley W,
- Bazhenova LA,
- Borghaei H,
- Camidge DR, et al.
- 3.↵
- Kris MG,
- Johnson BE,
- Berry LD,
- Kwiatkowski DJ,
- Iafrate AJ,
- Wistuba 2, et al.
- 4.↵
- Baxevanis CN,
- Perez SA.
- 5.↵
- Pardoll DM.
- 6.↵
- 7.
- Herbst RS,
- Soria JC,
- Kowanetz M,
- Fine GD,
- Hamid O,
- Gordon MS, et al.
- 8.↵
- Topalian SL,
- Hodi FS,
- Brahmer JR,
- Smith DC,
- Mcdermott DF,
- Carvajal RD, et al.
- 9.↵
- 10.↵
- 11.↵
- Herbst RS,
- Baas P,
- Kim DW,
- Felip E,
- Pérez-Gracia JL,
- Han JY, et al.
- 12.↵
- Spira AI,
- Park K,
- Mazieres J,
- Vansteenkiste JF,
- Rittmeyer A,
- Ballinger M, et al.
- 13.↵
- Parsa AT,
- Waldron JS,
- Panner A,
- Crane CA,
- Parney IF,
- Barry JJ, et al.
- 14.↵
- Marzec M,
- Zhang Q,
- Goradia A,
- Raghunath PN,
- Liu X,
- Paessler M, et al.
- 15.↵
- Ota K,
- Azuma K,
- Kawahara A,
- Hattori S,
- Iwama E,
- Tanizaki J, et al.
- 16.↵
- Akbay EA,
- Koyama S,
- Carretero J,
- Altabef A,
- Tchaicha JH,
- Christensen CL, et al.
- 17.↵
- 18.↵
- 19.↵
- Koh J,
- Go H,
- Keam B,
- Kim MY,
- Nam SJ,
- Kim TM, et al.
- 20.↵
- Lin C,
- Chen X,
- Li M,
- Liu J,
- Qi X,
- Yang W, et al.
- 21.↵
- 22.↵
- Ribas A.
- 23.↵
- Flies DB,
- Chen L.
- 24.↵
- Lee SJ,
- Jang BC,
- Lee SW,
- Yang Y,
- Suh SI,
- Park YM, et al.
- 25.↵
- Taube JM,
- Klein A,
- Brahmer JR,
- Xu H,
- Pan X,
- Kim JH, et al.
- 26.↵
- Freeman GJ,
- Long AJ,
- Iwai Y,
- Bourque K,
- Chernova TA,
- Fitz LJ, et al.
- 27.↵
- Taube JM,
- Anders RA,
- Young GD,
- Xu H,
- Sharma R,
- Mcmiller TL, et al.
- 28.↵
- Tumeh PC,
- Harview CL,
- Yearley JH,
- Shintaku IP,
- Taylor EJ,
- Robert L, et al.
- 29.↵
- 30.↵
- 31.↵
- 32.↵
- 33.↵
- Barsoum IB,
- Smallwood CA,
- Siemens DR,
- Graham CH.
- 34.↵
- Noman MZ,
- Desantis G,
- Janji BA,
- Karray S,
- Dessen P,
- Bronte V, et al.
- 35.↵
- 36.↵
- Boland JM,
- Kwon ED,
- Harrington SM,
- Tang H,
- Yang P,
- Aubry MC.
- 37.↵
- 38.
- 39.
- 40.
- 41.
- 42.↵
- 43.↵
- Konishi J,
- Yamazaki K,
- Azuma M,
- Kinoshita I,
- Dosaka-Akita H,
- Nishimura M.
- 44.
- 45.↵
- 46.↵
- Velcheti V,
- Schalper KA,
- Carvajal DE,
- Syrigos KN,
- Sznol MA,
- Gettinger SN, et al.
- 47.↵
- 48.↵
- 49.↵
- Huynh T,
- Oyarvide VM,
- Uruga H,
- Bozkurtlar E,
- Gainor JF,
- Hata AN, et al.
- 50.↵
- Harbison CT,
- Kurland JF,
- Horak CE,
- Cogswell JP,
- Inzunza HD,
- Hu X, et al.
- 51.↵
- 52.↵
- Rizvi NA,
- Brahmer JR,
- Ou S-HI,
- Segal NH,
- Khleif S,
- Hwu WJ, et al.
- 53.↵
- Hato SV,
- Khong A,
- De Vries IJ,
- Lesterhuis WJ.
- 54.↵
- Bozkurtlar E,
- Uruga H,
- Huynh T,
- Lanuti M,
- Mark E,
- Mino-Kenudson M.
- 55.↵
- Tokito T,
- Azuma K,
- Kawahara A,
- Ish2 H,
- Yamada K,
- Matsuo N, et al.
- 56.↵
- Teixido C,
- Karachaliou N,
- Gonzalez-Cao M,
- Morales-Espinosa D,
- Rosell R.
- 57.↵
- McLaughlin J,
- Han G,
- Schalper KA,
- Carvajal-Hausdorf D,
- Pelekanou V,
- Rehman J, et al.
- 58.↵
- Ilie M,
- Long-Mira E,
- Bence C,
- Butori C,
- Lassalle S,
- Bouhlel L, et al.
- 59.↵
- Kim J,
- Sorensen SF,
- Choi Y-L,
- Wang Z,
- Sun JM,
- Chio H, et al.
- 60.↵
- Rizvi NA,
- Hellmann MD,
- Snyder A,
- Kvistborg P,
- Makarov V,
- Havel JJ, et al.
- 61.↵
- Ribas A,
- Robert C,
- Hodi FS,
- Wolchok JD,
- Joshua AM,
- Hwu WJ, et al.
In this issue
Programmed cell death ligand-1 (PD-L1) expression by immunohistochemistry: could it be predictive and/or prognostic in non-small cell lung cancer?
Mari Mino-Kenudson
Cancer Biology & Medicine Jun 2016, 13 (2) 157-170; DOI: 10.20892/j.issn.2095-3941.2016.0009
Jump to section
- Article
- Abstract
- Introduction
- Mechanisms of PD-L1 expression (Table 1)
- PD-L1 expression and clinicopathologic and molecular correlation in NSCLC
- Prognostic role of PD-L1 expression in NSCLC
- PD-L1 expression as a predictive marker
- Issues associated with PD-L1 IHC
- Other possible markers to predict response to anti-PD-1/PD-L1 agents
- Conclusions
- Acknowledgements
- Footnotes
- References
- Figures & Data
- References
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Prediction of Responsiveness to PD-L1/PD-1 Inhibitors Using miRNA Profiles Associated With PD-L1 Expression in Lung Adenocarcinoma and Squamous Cell Carcinoma
- A Case Report of Metachronous Multiple Adenosquamous Carcinoma of the Colon Over-expressing PD-L1 and a Literature Review
- CAMOIP: A Web Server for Comprehensive Analysis on Multi-Omics of Immunotherapy in Pan-cancer
- The Prognostic Value of Programmed Death-ligand 1 (PD-L1) in Patients who Received Neoadjuvant Chemoradiation Therapy Followed by Surgery for Locally Advanced Non-small Cell Lung Cancer